GE HealthCare Technologies Inc. (gehc)

GEHC — Company Overview

GE HealthCare Technologies Inc. (GEHC) trades on NMS as part of the Healthcare peer group (Medical Devices).

GEHC — Business Description

GEHC represents a Medical Devices business in the Healthcare segment. GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring…

Official website: https://www.gehealthcare.com.

GEHC — Investment Thesis

At a high level, GEHC offers exposure to Healthcare with metrics outlined below from public market data.

• Revenue is expanding at roughly 5.8% year-over-year (public data).
• Trailing P/E of 15.26× sits in a moderate band relative to high-growth peers.
• Forward P/E (12.21×) is below trailing P/E — earnings may be expected to improve.
• Equity market capitalization is approximately $29.85B.

See the free estimates and earnings pages for public targets and growth metrics. Ownership, live news, and deeper models remain in Vest Terminal.

GEHC — Financial Health

Key financial health indicators for GE HealthCare Technologies Inc. are derived exclusively from public data — no proprietary estimates.

Profit margin near 9.3% leaves a narrower cushion versus higher-margin peers. Positive free cash flow of $1.57B supports balance-sheet flexibility.

GEHC — Growth Outlook

Growth outlook for GE HealthCare Technologies Inc. (GEHC) depends on demand trends in Medical Devices and the company's ability to convert revenue into sustainable earnings.

• Revenue growth of 5.8% suggests steady but measured expansion.
• Earnings growth of 16.8% year-over-year supports improving profitability.
• Price is 26.4% below the 52-week high.
• Shares trade 12.5% above the 52-week low — limited rebound so far.

GEHC — Competitive Position

GE HealthCare Technologies Inc. (GEHC) is evaluated against peers on scale, margin structure, and capital efficiency within Healthcare.

• Competes within Healthcare, specifically in Medical Devices.
• Market capitalization of $29.85B places GEHC among large-cap peers.
• Gross margin of 39.5% should be benchmarked against direct competitors.

GEHC — Summary

GE HealthCare Technologies Inc. (GEHC) is a large-cap Healthcare company focused on Medical Devices, listed on NMS. Last price $66.09 with market cap $29.85B. Trailing P/E 15.26×. Revenue grew 5.8% year-over-year per public data. Notable strengths include revenue growth of 5.8% year-over-year. Key watch items include price 26% below the 52-week high — sustained negative sentiment. Premium Terminal tools for GE HealthCare Technologies Inc. add ownership analytics, news, and richer estimate history beyond this public summary.